Treatment

Pause in immunosuppressive treatment results in improved immune response to SARS-CoV-2 vaccine in autoimmune patient: a case report
Basil Golding, Youri Lee, Hana Golding, Surender Khurana

Annals of the Rheumatic Diseases Jul 2021, annrheumdis-2021-220993; DOI: 10.1136/annrheumdis-2021-220993
Response to: ‘New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS’ by Assan et al
Martin Aringer, Karen Costenbader, Thomas Dörner, Sindhu R Johnson

Annals of the Rheumatic Diseases Aug 2021, 80 (8) e123; DOI: 10.1136/annrheumdis-2019-216250
Circulating regulatory T cells were absolutely decreased in dermatomyositis/polymyositis patients and restored by low-dose IL-2
Sheng-Xiao Zhang, Jia Wang, He-Hua Sun, Jia-Qian Zhang, Guang-Ying Liu, Jing Luo, Pei-Feng He, Xiao-Feng Li

Annals of the Rheumatic Diseases Aug 2021, 80 (8) e130; DOI: 10.1136/annrheumdis-2019-216246
Response to: ‘Diabetes mellitus in ankylosing spondylitis’ by Liao et al
Sylvain Mathieu, Martin Soubrier

Annals of the Rheumatic Diseases Aug 2021, 80 (8) e135; DOI: 10.1136/annrheumdis-2019-216249
Response to: ‘Novel NLRP12 variant presenting with familial cold autoimmunity syndrome phenotype’ by Gupta et al
Charlotte Eijkelboom, Nienke M Ter Haar, Joost Frenkel, Marco Gattorno

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e118; DOI: 10.1136/annrheumdis-2019-216184
How to use the Lupus Low Disease Activity State (LLDAS) in clinical trials
Ioannis Parodis, Mandana Nikpour

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e119; DOI: 10.1136/annrheumdis-2019-215650
Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?
Emanuel Raschi, Ippazio Cosimo Antonazzo, Elisabetta Poluzzi, Fabrizio De Ponti

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e120; DOI: 10.1136/annrheumdis-2019-215819
Aortic dilatation in a patient with Takayasu arteritis treated with tocilizumab
Francesco Muratore, Carlo Salvarani

Annals of the Rheumatic Diseases Jul 2021, 80 (7) e121; DOI: 10.1136/annrheumdis-2019-215459
Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studies
Johanna Maria Maassen, Raquel Dos Santos Sobrín, Sytske Anne Bergstra, Robbert Goekoop, Tom W J Huizinga, Cornelia F Allaart

Annals of the Rheumatic Diseases May 2021, annrheumdis-2021-220403; DOI: 10.1136/annrheumdis-2021-220403
Efficacy and safety of tofacitinib versus baricitinib in patients with rheumatoid arthritis in real clinical practice: analyses with propensity score-based inverse probability of treatment weighting
Yusuke Miyazaki, Kazuhisa Nakano, Shingo Nakayamada, Satoshi Kubo, Yoshino Inoue, Yoshihisa Fujino, Yoshiya Tanaka

Annals of the Rheumatic Diseases Apr 2021, annrheumdis-2020-219699; DOI: 10.1136/annrheumdis-2020-219699

Main menu

Treatment

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Treatment

Pages